Ph.D., Founder and CEO, Loop Genomics
Dr. Ben-Yehezkel founded Loop Genomics in 2016 as part of the Y-Combinator accelerator in order to disrupt the long-read sequencing space. Prior to Loop Genomics Dr. Ben-Yehezkel was the CEO and co-founder of Synvaccine, a viral synthetic genome engineering company and a Senior Scientist at the Weizmann Institute of Science, where he developed methods for engineering synthetic organisms. At Loop Genomics, he is directing the development and commercialization of the first hardware-free synthetic long read sequencing technology that can be used for any sequencing application. Loop’s technology transforms short-read sequencers into single-molecule long-read sequencers, offering the accuracy and resolution required for precision Microbiome, Transcriptome and DNA sequencing.
Clinical & Research Tools Showcase: Loop Genomics
Loop Genomics technology transforms short-read sequencers into long-read single-molecule machines for research and clinical applications.
Loop Genomics LoopSeqTM Single-Molecule Long-Read Sequencing
Loop Genomics has developed a sequencing technology that leverages existing Illumina short read sequencers coupled with barcoding technology to enable single-molecule, long-read sequencing on any Illumina infrastructure for Microbiome, Transcriptome, Targeted Amplicons and other applications.